← Leaderboards
Paul McGonigle
Psychogenics, Inc.
$1,350,000
Attributed
$1,350,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $450K · FY2008–10$500K$375K$250K$125K$0
'08
'09
'10
Funding mix
By agency
NIH$1,350,000 · 1
By mechanism
R44$1,350,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Psychogenics, Inc.
Same institution · by research overlap
- Barbara J. Caldarone$943,262
- Werner Tueckmantel$944,482
- Emer Leahy$51,449,430
- David Anthony Lowe$681,938
- Taleen G Hanania$1,607,051
Others in their field
Top investigators on “Complement”
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$128,874,888
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Steve Riordan · Westat, Inc.$94,143,268
- David R. Weir · University Of Michigan At Ann Arbor$93,718,087
- Stuart L Schreiber · Harvard University (Medical School)$88,512,978
Research focus
ComplementCostCardiotoxicityClozapineComputational ChemistryComputerized ToolsAnalogAdverse EffectsChronicCellular PathologyComplexAntidepressive AgentsAttention Deficit Hyperactivity DisorderBaseBehaviorBehavioralBehavioral AssayAnxietyBiological AvailabilityAnalytical ToolBupropionAreaArtsCytochrome P450